Quality of life in 244 recipients of allogeneic bone marrow transplantation

S. Chiodi, S. Spinelli, G. Ravera, A. R. Petti, M. T. Van Lint, T. Lamparelli, F. Gualandi, D. Occhini, N. Mordini, G. Berisso, S. Bregante, F. Frassoni, A. Bacigalupo

Research output: Contribution to journalArticle

151 Citations (Scopus)

Abstract

The number of long-term survivors after allogeneic bone marrow transplantation (BMT) has been increasing over the past years, and quality of life (QOL) has become an important end-point. We studied 244 patients undergoing an allogeneic BMT to identify factors and events influencing psychosocial outcome. Patients enrolled received the Psychosocial Adjustment to Illness Scale (PAIS) questionnaire assessing psychological and social adjustment to chronic illness or its sequelae. Eighty-two per cent of patients had a haematological disease. The median age was 28 years at BMT, and the median follow-up was 61 months. The median overall PAIS score for all patients was 56 (range 22-76): 25% (n = 61) of patients were considered to have a good QOL (≤ 25 percentile score); 44% (n = 108) of patients had an intermediate QOL (26-75 percentile score) and 31% (n = 75) had a poor QOL (> 75 percentile score). Factors associated with a poor QOL in multivariate analysis were: patients' age at BMT (> 25 years, P <0.01); presence of long-term sequelae (P <0.01); chronic graft-versus-host disease (GVHD) (P <0.05); and a short interval from BMT (<5 years: P <0.05). The QOL improved with time: 12% of patients reported a good QOL within 5 years compared with 38% after this time point and, conversely, 38% reported a poor QOL within 5 years compared with 24% after this time point (P <0.0001). Older patients had significantly poorer QOL compared with younger patients (≤ 25 years; P = 0.01). Females had significantly poorer scores when compared with males in the sexual (P <0.0001) and psychological domains (P = 0.001). The data suggest that (i) one-third of patients undergoing allogeneic BMT report a poor QOL; (ii) factors associated with poor QOL are older age, presence of long-term sequelae, chronic GVHD and short follow-up; (iii) QOL is superior in long-term survivors; and (iv) BMT affects different aspects of life in males and females. A longitudinal study is ongoing to prove the effect of time on quality of life.

Original languageEnglish
Pages (from-to)614-619
Number of pages6
JournalBritish Journal of Haematology
Volume110
Issue number3
DOIs
Publication statusPublished - 2000

Fingerprint

Homologous Transplantation
Bone Marrow Transplantation
Quality of Life
Social Adjustment
Graft vs Host Disease
Survivors
Hematologic Diseases
Longitudinal Studies
Chronic Disease
Multivariate Analysis

Keywords

  • Allogeneic bone marrow transplantation
  • Psychosocial adjustment
  • Quality of life

ASJC Scopus subject areas

  • Hematology

Cite this

Quality of life in 244 recipients of allogeneic bone marrow transplantation. / Chiodi, S.; Spinelli, S.; Ravera, G.; Petti, A. R.; Van Lint, M. T.; Lamparelli, T.; Gualandi, F.; Occhini, D.; Mordini, N.; Berisso, G.; Bregante, S.; Frassoni, F.; Bacigalupo, A.

In: British Journal of Haematology, Vol. 110, No. 3, 2000, p. 614-619.

Research output: Contribution to journalArticle

Chiodi, S. ; Spinelli, S. ; Ravera, G. ; Petti, A. R. ; Van Lint, M. T. ; Lamparelli, T. ; Gualandi, F. ; Occhini, D. ; Mordini, N. ; Berisso, G. ; Bregante, S. ; Frassoni, F. ; Bacigalupo, A. / Quality of life in 244 recipients of allogeneic bone marrow transplantation. In: British Journal of Haematology. 2000 ; Vol. 110, No. 3. pp. 614-619.
@article{5c0fcdd1575c4bf994a747834abfe2fc,
title = "Quality of life in 244 recipients of allogeneic bone marrow transplantation",
abstract = "The number of long-term survivors after allogeneic bone marrow transplantation (BMT) has been increasing over the past years, and quality of life (QOL) has become an important end-point. We studied 244 patients undergoing an allogeneic BMT to identify factors and events influencing psychosocial outcome. Patients enrolled received the Psychosocial Adjustment to Illness Scale (PAIS) questionnaire assessing psychological and social adjustment to chronic illness or its sequelae. Eighty-two per cent of patients had a haematological disease. The median age was 28 years at BMT, and the median follow-up was 61 months. The median overall PAIS score for all patients was 56 (range 22-76): 25{\%} (n = 61) of patients were considered to have a good QOL (≤ 25 percentile score); 44{\%} (n = 108) of patients had an intermediate QOL (26-75 percentile score) and 31{\%} (n = 75) had a poor QOL (> 75 percentile score). Factors associated with a poor QOL in multivariate analysis were: patients' age at BMT (> 25 years, P <0.01); presence of long-term sequelae (P <0.01); chronic graft-versus-host disease (GVHD) (P <0.05); and a short interval from BMT (<5 years: P <0.05). The QOL improved with time: 12{\%} of patients reported a good QOL within 5 years compared with 38{\%} after this time point and, conversely, 38{\%} reported a poor QOL within 5 years compared with 24{\%} after this time point (P <0.0001). Older patients had significantly poorer QOL compared with younger patients (≤ 25 years; P = 0.01). Females had significantly poorer scores when compared with males in the sexual (P <0.0001) and psychological domains (P = 0.001). The data suggest that (i) one-third of patients undergoing allogeneic BMT report a poor QOL; (ii) factors associated with poor QOL are older age, presence of long-term sequelae, chronic GVHD and short follow-up; (iii) QOL is superior in long-term survivors; and (iv) BMT affects different aspects of life in males and females. A longitudinal study is ongoing to prove the effect of time on quality of life.",
keywords = "Allogeneic bone marrow transplantation, Psychosocial adjustment, Quality of life",
author = "S. Chiodi and S. Spinelli and G. Ravera and Petti, {A. R.} and {Van Lint}, {M. T.} and T. Lamparelli and F. Gualandi and D. Occhini and N. Mordini and G. Berisso and S. Bregante and F. Frassoni and A. Bacigalupo",
year = "2000",
doi = "10.1046/j.1365-2141.2000.02053.x",
language = "English",
volume = "110",
pages = "614--619",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "John Wiley & Sons, Ltd (10.1111)",
number = "3",

}

TY - JOUR

T1 - Quality of life in 244 recipients of allogeneic bone marrow transplantation

AU - Chiodi, S.

AU - Spinelli, S.

AU - Ravera, G.

AU - Petti, A. R.

AU - Van Lint, M. T.

AU - Lamparelli, T.

AU - Gualandi, F.

AU - Occhini, D.

AU - Mordini, N.

AU - Berisso, G.

AU - Bregante, S.

AU - Frassoni, F.

AU - Bacigalupo, A.

PY - 2000

Y1 - 2000

N2 - The number of long-term survivors after allogeneic bone marrow transplantation (BMT) has been increasing over the past years, and quality of life (QOL) has become an important end-point. We studied 244 patients undergoing an allogeneic BMT to identify factors and events influencing psychosocial outcome. Patients enrolled received the Psychosocial Adjustment to Illness Scale (PAIS) questionnaire assessing psychological and social adjustment to chronic illness or its sequelae. Eighty-two per cent of patients had a haematological disease. The median age was 28 years at BMT, and the median follow-up was 61 months. The median overall PAIS score for all patients was 56 (range 22-76): 25% (n = 61) of patients were considered to have a good QOL (≤ 25 percentile score); 44% (n = 108) of patients had an intermediate QOL (26-75 percentile score) and 31% (n = 75) had a poor QOL (> 75 percentile score). Factors associated with a poor QOL in multivariate analysis were: patients' age at BMT (> 25 years, P <0.01); presence of long-term sequelae (P <0.01); chronic graft-versus-host disease (GVHD) (P <0.05); and a short interval from BMT (<5 years: P <0.05). The QOL improved with time: 12% of patients reported a good QOL within 5 years compared with 38% after this time point and, conversely, 38% reported a poor QOL within 5 years compared with 24% after this time point (P <0.0001). Older patients had significantly poorer QOL compared with younger patients (≤ 25 years; P = 0.01). Females had significantly poorer scores when compared with males in the sexual (P <0.0001) and psychological domains (P = 0.001). The data suggest that (i) one-third of patients undergoing allogeneic BMT report a poor QOL; (ii) factors associated with poor QOL are older age, presence of long-term sequelae, chronic GVHD and short follow-up; (iii) QOL is superior in long-term survivors; and (iv) BMT affects different aspects of life in males and females. A longitudinal study is ongoing to prove the effect of time on quality of life.

AB - The number of long-term survivors after allogeneic bone marrow transplantation (BMT) has been increasing over the past years, and quality of life (QOL) has become an important end-point. We studied 244 patients undergoing an allogeneic BMT to identify factors and events influencing psychosocial outcome. Patients enrolled received the Psychosocial Adjustment to Illness Scale (PAIS) questionnaire assessing psychological and social adjustment to chronic illness or its sequelae. Eighty-two per cent of patients had a haematological disease. The median age was 28 years at BMT, and the median follow-up was 61 months. The median overall PAIS score for all patients was 56 (range 22-76): 25% (n = 61) of patients were considered to have a good QOL (≤ 25 percentile score); 44% (n = 108) of patients had an intermediate QOL (26-75 percentile score) and 31% (n = 75) had a poor QOL (> 75 percentile score). Factors associated with a poor QOL in multivariate analysis were: patients' age at BMT (> 25 years, P <0.01); presence of long-term sequelae (P <0.01); chronic graft-versus-host disease (GVHD) (P <0.05); and a short interval from BMT (<5 years: P <0.05). The QOL improved with time: 12% of patients reported a good QOL within 5 years compared with 38% after this time point and, conversely, 38% reported a poor QOL within 5 years compared with 24% after this time point (P <0.0001). Older patients had significantly poorer QOL compared with younger patients (≤ 25 years; P = 0.01). Females had significantly poorer scores when compared with males in the sexual (P <0.0001) and psychological domains (P = 0.001). The data suggest that (i) one-third of patients undergoing allogeneic BMT report a poor QOL; (ii) factors associated with poor QOL are older age, presence of long-term sequelae, chronic GVHD and short follow-up; (iii) QOL is superior in long-term survivors; and (iv) BMT affects different aspects of life in males and females. A longitudinal study is ongoing to prove the effect of time on quality of life.

KW - Allogeneic bone marrow transplantation

KW - Psychosocial adjustment

KW - Quality of life

UR - http://www.scopus.com/inward/record.url?scp=0033777112&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033777112&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2141.2000.02053.x

DO - 10.1046/j.1365-2141.2000.02053.x

M3 - Article

VL - 110

SP - 614

EP - 619

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 3

ER -